SPARK

Joint Enterprise Technology Tool (JETT)

Serving the joint force requires speed, agility, and innovation. The Joint Enterprise Technology Tool (JETT) allows JPEO-CBRND to connect our mission to the innovative technologies that accelerate results for our warfighters.”

Joint Enterprise Technology Tool

Contracting Overview

JPEO-CBRND's mission to provide the best CBRN defense technology and equipment to our warfighters is only possible with participation from industry. Industry performers play a vital role in supporting the Joint Force and our Nation's defense.

Contracting Focus Area

Multiple Award Task Order Contract (MATOC)

MATOCs promote competition, save costs, encourage small business participation, minimize time to award, and streamline documentation. The MATOCs are managed by the Contracting Office. Click below for opportunities in each contract area.

Downloads

Other Transactions Agreements (OTA)

OTAs enable DOW to access technologies from non-traditional partners. OTAs are managed by the JPEO-CBRND's Contracting Office. Click below for opportunities in each OTA contract area.

Links

Alternative Contracts

Stand Alone Contracts

No "one size fits all" model exists for CBRND product development and production. Each collaboration is as unique as the product. Considerations in selection of vehicles range from acquisition history, urgency of requirement, complexity of requirement as well as other factors.

Learn more about the stand-alone contracts through our JPEO-CBRND Contracting Office and through the General Services Administration's SAM.gov

JPM CBRN Medical TechWatch

JPM CBRN Medical plays a vital role in enhancing the U.S. Department of War’s strategy to prevent, diagnose and treat the effects of chemical, biological, radiological and nuclear (CBRN) threats and emerging infectious diseases.

Opportunities through a public-private partnership to help JPM CBRN Medical in the advanced development and acquisition of safe, effective and innovative medical solutions and systems to combat CBRN and other emerging infectious diseases.